The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia

What Was Tested

Researchers studied L-Carnitine in this randomized controlled trial publication.

The aim of this study was to determine the effect of L-carnitine on echocardiographic changes in β-thalassemia major and intermedia patients in Besat Hospital in Sanandaj, Iran.

Who Took Part

The age groups tagged for this paper are young children, children, teenagers, young adults and adults, both men and women.

In a randomized clinical trial, 60 β-thalassemia patients who were eligible for L-carnitine administration were randomly divided into 2 placebo and study drug groups.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Because people in this L-Carnitine study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind L-Carnitine study, the assignments were hidden from both participants and investigators until the end.

The comparison arm used a placebo, so changes seen with L-Carnitine could be set against what happens without it.

The duration of the study was 6 months.

Using echocardiography and blood tests, cardiac parameters including left ventricular dilatation, left ventricular hypertrophy, and a number of cardiac blood indices were examined before and after the intervention.

The data were analyzed using SPSS V.23 software, χ, and covariance statistical tests.

What Was Measured

The subject headings attached to it are Arrhythmias, Cardiac, Carnitine, Case-Control Studies, Echocardiography, Prognosis and beta-Thalassemia.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of L-Carnitine.

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (Journal of pediatric hematology/oncology), a journal based in United States.

More context: the L-Carnitine compound page, all human trials.